Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

SMBC Nikko Downgrades Jounce Therapeutics to Neutral

SMBC Nikko analyst David Dai downgrades Jounce Therapeutics (NASDAQ:JNCE) from Outperform to Neutral.
byBenzinga Newsdesk
February 24, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

SMBC Nikko analyst David Dai downgrades Jounce Therapeutics (NASDAQ:JNCE) from Outperform to Neutral.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Cenntro Electric Group’s LS400 Approved For California’s Hybrid And Zero-Emission Truck And Bus Voucher Incentive Project; Project Provides $60,000 Point-Of-Sale Vouchers For All-Electric Class 4 Logistar 400 Sales In The State Of California

By Benzinga Newsdesk
December 19, 9:44 AM
Project Provides $60,000 Point-of-Sale Vouchers for All-Electric Class 4 Logistar 400 Sales in the state of CaliforniaCenntro Electric Group Limited (NASDAQ:CENN) ("Cenntro" or "the Company"), a leading electric vehicle

CENN